AWS
GILD icon

Atria Wealth Solutions’s Gilead Sciences GILD Stock Holding History

Atria Wealth Solutions’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$3.19M Sell
28,670
-18,984
-40% -$2.02M 0.07% 300
2025
Q1 		$5.34M Sell
47,654
-10,807
-18% -$1.12M 0.06% 320
2024
Q4 		$5.4M Sell
58,461
-2,703
-4% -$243K 0.06% 337
2024
Q3 		$5.13M Sell
61,164
-13,757
-18% -$1.05M 0.06% 342
2024
Q2 		$5.14M Sell
74,921
-751
-1% -$50.1K 0.06% 336
2024
Q1 		$5.54M Sell
75,672
-4,823
-6% -$371K 0.06% 311
2023
Q4 		$6.52M Buy
80,495
+338
+0.4% +$26.3K 0.08% 245
2023
Q3 		$6.01M Buy
80,157
+207
+0.3% +$15.9K 0.08% 246
2023
Q2 		$6.16M Sell
79,950
-8,233
-9% -$657K 0.08% 234
2023
Q1 		$7.32M Sell
88,183
-3,655
-4% -$303K 0.11% 185
2022
Q4 		$7.88M Buy
91,838
+2,599
+3% +$206K 0.13% 174
2022
Q3 		$5.51M Buy
89,239
+26,994
+43% +$1.7M 0.1% 213
2022
Q2 		$3.85M Sell
62,245
-22,003
-26% -$1.36M 0.07% 281
2022
Q1 		$5.01M Buy
+84,248
New +$5.39M 0.08% 253

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Atria Wealth Solutions's GILD Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Gilead Sciences (GILD) stake by 40% in Q2 2025, selling an estimated $2.02M and leaving 28,670 shares worth $3.19M. The position accounts for 0.07% of the portfolio, ranked #300.

Atria Wealth Solutions first reported a position in GILD in Q1 2022 and has held it in 14 quarters since. The position peaked at $7.88M in Q4 2022. 2,026 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Atria Wealth Solutions held 28,670 shares of Gilead Sciences worth $3.19M as of Q2 2025.
  • Atria Wealth Solutions sold 18,984 Gilead Sciences shares in Q2 2025, an estimated $2.02M.
  • Gilead Sciences made up 0.07% of Atria Wealth Solutions's portfolio in Q2 2025, its #300 holding.
  • Atria Wealth Solutions first reported a position in Gilead Sciences in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's Gilead Sciences position peaked at $7.88M in Q4 2022.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.